A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.

MLA

Carter, Brandon, et al. “A Pan-Variant MRNA-LNP T Cell Vaccine Protects HLA Transgenic Mice from Mortality after Infection with SARS-CoV-2 Beta.” Frontiers in Immunology, vol. 14, Mar. 2023, pp. 1–9. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1135815.

APA

Carter, B., Pinghan Huang, Ge Liu, Yuejin Liang, Lin, P. J. C., Bi-Hung Peng, McKay, L. G. A., Dimitrakakis, A., Hsu, J., Tat, V., Saenkham-Huntsinger, P., Jinjin Chen, Kaseke, C., Gaiha, G. D., Qiaobing Xu, Griffiths, A., Tam, Y. K., Tseng, C.-T. K., & Gifford, D. K. (2023). A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta. Frontiers in Immunology, 14, 1–9. https://doi.org/10.3389/fimmu.2023.1135815

Chicago

Carter, Brandon, Pinghan Huang, Ge Liu, Yuejin Liang, Paulo J. C. Lin, Bi-Hung Peng, Lindsay G. A. McKay, et al. 2023. “A Pan-Variant MRNA-LNP T Cell Vaccine Protects HLA Transgenic Mice from Mortality after Infection with SARS-CoV-2 Beta.” Frontiers in Immunology 14 (March): 1–9. doi:10.3389/fimmu.2023.1135815.